RxDoctor Payments Data

Ashley Peairs

Interventional Pain Medicine · Thibodaux, LANPI 1043698921

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Spinal Simplicity, LLC at 58.2% of the total. Reporting peaked in 2022 at $9,903 and has fallen 99.8% since, to $19 in 2024.

$16,616in general payments, 2019–2025

Across 187 payments — averaging $88.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$10K
  • Nevro Corp.$3K
  • Boston Scientific$2K
  • Relievant Medsystems, Inc.$1K
  • AbbVie$261
  • Medtronic$256
  • plus $589 from 12 others

What the payments were for

  • Travel & lodging$4,80229%
  • Food & beverage$4,86129%
  • Education$6,95342%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Spinal Simplicity, LLC20$9,667
Nevro Corp.49$3,123
Boston Scientific59$1,646
Relievant Medsystems, Inc.5$1,075
AbbVie(2 entities)15$261
Medtronic(2 entities)10$256
Abbott10$196
Collegium Pharmaceutical, Inc.7$132
Interventional Pain Technologies Inc.1$47
Amgen2$45
Vertiflex, Inc.1$34
Eisai Inc.2$31
Pfizer1$24
Averitas Pharma Inc.1$21
Redhill Biopharma Inc.1$18
Almatica Pharma LLC1$15
Virtus Pharmaceuticals LLC1$14
Arbor Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,616 in reported general payments places this provider in the 80th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl24$630
Gabapentin15$389
Meloxicam15$58

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →